Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration.
about
Anti-vascular endothelial growth factor for neovascular age-related macular degenerationMacular translocation for neovascular age-related macular degenerationSubmacular surgery for choroidal neovascularisation secondary to age-related macular degenerationMacular translocation for age-related macular degenerationAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degenerationSubmacular surgery for choroidal neovascularisation secondary to age-related macular degenerationAntiangiogenic therapy with interferon alfa for neovascular age-related macular degenerationAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degenerationInterferon alfa therapy for age-related macular degenerationClinical applications of optical coherence tomography in the posterior pole: the 2011 José Manuel Espino Lecture - Part IIProtocol: Effect of intravitreal bevacizumab (avastin) in the treatment of macular edema: A systematic review of randomized controlled trialsQuantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degenerationClinical use and research applications of Heidelberg retinal angiography and spectral-domain optical coherence tomography - a review.Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration.Retention of good visual acuity in eyes with neovascular age-related macular degeneration and chronic refractory subfoveal subretinal fluidOptical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials.Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study.Optical Coherence Tomography and the Development of Antiangiogenic Therapies in Neovascular Age-Related Macular Degeneration.Relationships between clinical measures of visual function and anatomic changes associated with bevacizumab treatment for choroidal neovascularization in age-related macular degeneration.Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration.Predicting visual outcomes for macular disease using optical coherence tomography.IDENTIFICATION OF FLUID ON OPTICAL COHERENCE TOMOGRAPHY BY TREATING OPHTHALMOLOGISTS VERSUS A READING CENTER IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENTS TRIALS.Optical coherence tomography in photodynamic therapy.Time-course and characteristic morphology of retinal changes following combination of verteporfin therapy and intravitreal triamcinolone in neovascular age-related macular degeneration.Mapping of the retinal pigment epithelium in exudative age related macular degeneration.[Monitoring of AMD patients on anti-vascular endothelial growth factor (VEGF) treatment. Practical notes on functional and anatomical examination parameters from drug approval studies, specialist information and case series].Correlation between components of newly diagnosed exudative age-related macular degeneration lesion and focal retinal sensitivity.Reproducibility of retinal thickness measurements in patients with age-related macular degeneration using 3D Fourier-domain optical coherence tomography (OCT) (Topcon 3D-OCT 1000).
P2860
Q24194251-6B014302-A6C8-4E8C-AA91-FB8EADAAFC90Q24241142-32AE272B-7FFD-46BC-ACE1-F897AA0F7E5AQ24241790-47ADD016-1045-4FA8-ACD6-3D29BB7230A5Q24243002-BEC82C0F-6497-46BE-82C2-F642C80F3F7EQ24243234-666BDBA8-2B92-42B7-B348-2D2A42142956Q24243677-BA469495-732F-417B-B8A3-5A0A140D5C1AQ24244534-7416495E-AA0A-44B5-B85D-7F29E5372E03Q24245483-83B84077-F90A-49A2-9199-61E1F7D88E54Q24246549-D62B2A3B-B801-4CC1-BB96-DEA011FFAED4Q26864721-E5F75C32-485A-4764-AEB1-66BA545AF045Q28680651-05CF761B-98E6-47DC-9615-1C3ED3E17DBFQ33402860-FA806288-6626-4324-B8BD-AA96114FE903Q33425451-21E3241F-D653-452D-8742-2C0351A9A2A5Q33606629-31AA03E4-30F2-4B10-9B5B-1A39F7246C0DQ33620442-E5B7B6E5-C13B-40A6-8721-ED6E33F13754Q34400706-99905FD7-CDCD-4DBE-A2A0-63DE3D7D10B7Q34705570-E86EF7DA-EC3B-44D5-A426-4E5015FF28B4Q35592940-FA9479BC-9A76-4D24-B2E7-EE7F207ED4B3Q37143095-EEB7DAA1-B9D8-4C6D-B69A-D4B1D6FD8696Q37336612-5987B8B5-A784-4559-BE43-AB4EA2A6B50CQ37684468-DCCEB17B-A563-4BBF-8D49-57E99F3461CAQ38130239-89F43093-EBE3-45AD-A0BE-4F7BFE2D8A40Q41987019-97B7E3C8-4E29-408E-B981-B222CEEFD062Q43007057-9401DED4-2CE2-42BF-A6DA-1B88768AA46CQ46240235-54326722-B756-4EA3-B924-DCBDAB32ADE8Q46678904-68413470-5D61-4875-B52F-9A2F9637C1D4Q46767253-BC801331-4EB8-4007-B5BD-339BAE1826F6Q50490403-A0857925-45DD-4024-A269-0256E50B389BQ51763358-27E31CCB-E138-4946-8E7B-CC84769E2697
P2860
Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Decreased visual acuity associ ...... -related macular degeneration.
@en
Decreased visual acuity associ ...... -related macular degeneration.
@nl
type
label
Decreased visual acuity associ ...... -related macular degeneration.
@en
Decreased visual acuity associ ...... -related macular degeneration.
@nl
prefLabel
Decreased visual acuity associ ...... -related macular degeneration.
@en
Decreased visual acuity associ ...... -related macular degeneration.
@nl
P2093
P1433
P1476
Decreased visual acuity associ ...... e-related macular degeneration
@en
P2093
Cynthia A Toth
T Daniel Ting
Terry A Cox
P304
P356
10.1001/ARCHOPHT.120.6.731
P407
P50
P577
2002-06-01T00:00:00Z